Loading organizations...
§ Private Profile · Shanghai, Shanghai, China
Tumor immunotherapy technology developer using CAR-T for cancer treatment.
Hrain Biotechnology has raised $57.2M across 2 funding rounds.
Hrain Biotechnology has raised $57.2M in total across 2 funding rounds.
Hrain Biotechnology has raised $57.2M across 2 funding rounds. Most recently, it raised $29.2M Series B in September 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 9, 2020 | $29.2M Series B | — | — | Announced |
| Oct 2, 2019 | $28M Series B | Shenzhen Capital Group | — | Announced |
Hrain Biotechnology has raised $57.2M in total across 2 funding rounds.
Hrain Biotechnology's investors include Shenzhen Capital Group.